Dr Jonathan N. Stea, Adjunct Assistant Professor at the University of Calgary
Dr Jonathan N. Stea is a Clinical Psychologist whose speciality is concurrent disorders. He is an "Adjunct Assistant Professor" at the University of Calgary.
His "antipsychiatry" label is just one example of what those in the prescribed harm community face on a daily basis on Twitter. It would appear that those who choose to go public about their experience with psychiatric medication are, according to Stea, deterring people from getting treatment and stigmatizing.
If one looks at the product labelling of any psychiatric medication one will find warnings of increased suicidality, withdrawal problems, sexual dysfunction, to name but a few.
Do we see the likes of Stea labelling the creators of the product labels, namely the drug companies and the regulators?
If, by speaking out about personal experiences, people are labelled by healthcare professionals such a Stea, what then for the drug companies and global regulators? Are they stigmatizing and antipsychiatry because they warn about the dangers of taking psychiatric medication?
Stea isn't the only one, there are many more 'professionals' on Twitter that try to silence those harmed by the very same pills they prescribe.
My question is simple:
Why such disdain for patients harmed by psychiatric medications?
Answers on a postcard to:
#PrescribedHarm
Bob Fiddaman
No comments: